moxisylyte has been researched along with Prostatitis in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Prostatitis: Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cléau, DL | 1 |
| Jobard, JM | 1 |
| Clerc, BM | 1 |
| Musquar, RJ | 1 |
| Clément, DL | 1 |
1 other study available for moxisylyte and Prostatitis
| Article | Year |
|---|---|
[Moxisylyte-induced acute hepatitis: a case].
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Humans; Male; Moxisylyte; Prostatitis | 1992 |